SUBGROUP-SPECIFIC DIAGNOSTIC, PROGNOSTIC, AND PREDICTIVE MARKERS INFLUENCING PEDIATRIC MEDULLOBLASTOMA TREATMENT

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment

Eye Drops Medulloblastoma (MB) is the most common malignant central nervous system tumor in pediatric patients.Mainstay of therapy remains surgical resection followed by craniospinal radiation and chemotherapy, although limitations to this therapy are applied in the youngest patients.Clinically, tumors are divided into average and high-risk status

read more


Nanoengineered approaches to improve the efficacy of targeted drug delivery for the treatment of malignancy: a comprehensive review

Abstract Background The second leading cause of mortality in the world, behind cardiovascular disorders, is cancer.The currently employed treatment options including radiotherapy, chemotherapy are reported with many adverse reactions.These limitations in combination with high cost of therapy have restricted the management of malignancy.In this revi

read more